Inside-out approach

Peregrine Pharmaceuticals Inc. is taking a different tack to the most popular approaches for attacking HCV, and is currently the only company with a compound targeting phosphatidylserine. It doesn't expect to be alone for long.

PPHM (Tustin, Calif.) last month

Read the full 390 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE